The Moral Costs of IVF Research

The Vatican's March 10 condemnation of artificial methods of reproduction, including in vitro fertilization (IVF), is certain to be the cause of considerable controversy both within and without the scientific community, and among Catholics and non-Catholics alike. The pronouncement by the Congregation for the Doctrine of the Faith says that "uncontrollable application of such techniques could lead to unforeseeable and damaging consequences for civil society." In addition to outlawing artificial

Written byDitta Bartels
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

It would be easy to dismiss the statement as another example of the church retreating from the advance of science, in this case a medical advance that has made it possible for thousands of infertile couples to have children. But the document embodies the moral concerns that many observers have regarding the use of embryos as experimental material. It is a document that Australia, with its burgeoning IVF industry, should study well.

Victoria, Australia, is already quite far along the path to the regulation of IVE In 1984, the Victorian Parliament passed the Infertility (Medical Procedures) Act, with most provisions coming into effect in August 1986. The Act specifies that all proposals for research on human embryos be cleared by a government-appointed committee, and provides for criminal penalties—including jail terms of up to four years—for researchers conducting unauthorized experiments or stepping beyond the committee's recommendation.

In certain cases, the law ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies